WELL-DIFFERENTIATED/DEDIFFERENTIATED LIPOSARCOMA

Clinical trials for WELL-DIFFERENTIATED/DEDIFFERENTIATED LIPOSARCOMA explained in plain language.

Never miss a new study

Get alerted when new WELL-DIFFERENTIATED/DEDIFFERENTIATED LIPOSARCOMA trials appear

Sign up with your email to follow new studies for WELL-DIFFERENTIATED/DEDIFFERENTIATED LIPOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug duo tested to fight aggressive Fat-Tissue cancer

Disease control Ongoing

This study is testing whether combining two drugs, palbociclib and INCMGA00012, is a safe and effective treatment for people with advanced liposarcoma, a type of cancer that arises in fat tissue. The trial will enroll 42 adults to see if this combination can shrink or control the…

Matched conditions: WELL-DIFFERENTIATED/DEDIFFERENTIATED LIPOSARCOMA

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

WELL-DIFFERENTIATED/DEDIFFERENTIATED LIPOSARCOMA

Get alerted when new WELL-DIFFERENTIATED/DEDIFFERENTIATED LIPOSARCOMA trials appear

New drug duo tested to fight aggressive Fat-Tissue cancer